JENNIFER MAHAN: Open Payments
NPI 1376039347 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,199 in 53 payments from 14 companies in 2025. Trend: 2023 $855 · 2024 $1,247 · 2025 $1,199
Food & beverage: $1,199
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $352 |
| Amgen Inc. | 5 | $180 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $152 |
| Novartis Pharmaceuticals Corporation | 7 | $150 |
| Janssen Biotech, Inc. | 4 | $85 |
| UCB, Inc. | 2 | $64 |
| Lilly USA, LLC | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Arcutis Biotherapeutics, Inc. | 2 | $34 |
| GENZYME CORPORATION | 1 | $27 |
Products named: SKYRIZI, OTEZLA, COSENTYX, RINVOQ, ILUMYA, TREMFYA, Bimzelx, TALTZ.
Industry payments across VA — which companies pay providers there.
